A Review: Genetic Mutations in Hemoglobin: Sickle Cell Anemia

Authors

  • Hutham Abd Ali Abd Al Hussain Dep. of chemistry, Collage of Education for pure science /University of Karbala, Karbala, Iraq.
  • Shymaa Hamzah Daylee Dep. of chemistry, Collage of Education for pure science /University of Karbala, Karbala, Iraq.
  • Radhiah Najm Abd Dep. of physics, Collage of Education for pure science /University of Karbala

Keywords:

Sickle cell anemia, Hemoglobin, B chain, Mutate, and heredity diseases.

Abstract

An irreversible, heritable change to the nucleotide sequence of a gene or chromosome is referred to as a mutation, or in the method through which such a shift takes place. Small-scale and large-scale mutations fall under the two groups of mutations. When one or more nucleotides are changed, removed, or added, small-scale mutations take place in the DNA. Large-scale mutations are those that arise in a specific region of a chromosome. This type of mutation has the potential to be fatal or cause significant damage, Mutations can be classified as small scale or large scale depending on their influence on the gene structure. Anemia and severe pain are symptoms of the hereditary condition sickle cell anemia. People with the illness have a defective gene that contributes to the creation of the protein hemoglobin, which carries oxygen in erythrocytes. People who carry two copies of the sickle cell gene are more likely to develop sickle cell disease. Sickle cell illness does not afflict people who have only one copy of the sickle cell gene, but their descendants may get it from them.

References

Judy C. Chang, Lin Ye, and Yuet Wai Kan. (Jan, 11 ,2006). Correction of the sickle cell mutation in embryonic stem cells. Pnas. Published online.

Suzanne Clancy, Ph.D. (2008). Genetic Mutation. Clancy, S. Genetic mutation. Nature Education 1(1):187

Deepti Mutreja, Benjith Paul K, Tilak TVSVGK. (2021). Fatal sickling-associated microvascular occlusive crisis in a young with sickle cell trait. Autopsy and casereports. vol.11, e2021297.

Tapper, Melbourne Ximines. (1990). The signifying disease: Difference, discrimination and the discourse of sickle cell anemia. University of Connecticut. ProQuest Dissertations Publishing.

Frédéric B Piel. Thomas N. , Williams. ( 30 March 2016). Sickle Cell Anemia: History and Epidemiology. Springer. 23-47.

Jecko Thachil, Shirley Owusu-Ofori, Imelda Bates. (2013 Oct 21). Manson's Tropical Infectious Diseases. Elsevier Public Health Emergency Collection. 894–932. doi: 10.1016/B978-0-7020-5101-2.00066-2.

P D'Eustachio, G C Owens, G M Edelman, and B A Cunningham. (November 1, 1985). Chromosomal location of the gene encoding the neural cell adhesion molecule (N-CAM) in the mouse. PNAS. 7631-7635. https://doi.org/10.1073/pnas.82.22.7631

Vijay G. Sankaran, Stuart H. Orkin. (2021). The Switch from Fetal to Adult Hemoglobin. Cold Spring Harbor Perspectives in Medicine. 11,9.

David C. Jinks, Mikeanne Minter, Deborah A. Tarver, Mindy Vanderford, J. Fielding Hejtmancik & Edward R. B. McCabe. (1989). Molecular genetic diagnosis of sickle cell disease using dried blood specimens on blotters used for newborn screening. Original Investigations. 363–366.

Saaliha Vali,Sunbal Mukhtar,Anupa Nandi,Kieren Wilson,Laura Oakley,Tarek El-Toukhy,Eugene Oteng-Ntim. (04 July 2020). Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease. British Journal of Haematology. Volume191. Issue5. Pages 875-879.

MonicaAttiaBS1, ShawnKripalaniMS, BS1, IshaDarbariBS2Robert SheppardNickelMD. (August 2020). Parents of Children with Sickle Cell Disease Are Interested in Preimplantation Genetic Testing. The Journal of Pediatrics. Volume 223. Pages 178-182.e2.

Ambroise Wonkam,Emile R. Chimusa,Khuthala Mnika,Gift Dineo Pule,Valentina Josiane Ngo Bitoungui,Nicola Mulder,Daniel Shriner,Charles N. Rotimi,Adebowale Adeyemo. (2020). Genetic modifiers of long-term survival in sickle cell anemia. Clinical and Translational Medicine. Volume 11, Issue 9. e152.

Françoise Bernaudin,1,2 Jean-Hugues Dalle, other. (2019). Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in Franc. Haematologica. Pmid: 31097628.

Jeffrey D. Lebensburger, Gary R. Cutter, Thomas H. Howard, Paul Muntner & Daniel I. Feig. (2017). Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia. Pediatric Nephrology volume. 32. 1565–1573.

Ambroise Wonkam,Emile R. Chimusa,Khuthala Mnika,Gift Dineo Pule,Valentina Josiane Ngo Bitoungui,Nicola Mulder,Daniel Shriner,Charles N. Rotimi,Adebowale Adeyemo. (2020). Genetic modifiers of long-term survival in sickle cell anemia. Clinical and Translational MedicineVolume10, Issue4. e152.

Robert I. Liem. (2018). Balancing exercise risk and benefits: lessons learned from sickle cell trait and sickle cell anemia. Hematology Am Soc Hematol Educ Program. Volume 2018.

JOHN F. TISDALESWEE LAY THEINAND WILLIAM A. EATON. (2020). Treating sickle cell anemia. Science. Vol 367, Issue 6483. pp. 1198-1199. DOI: 10.1126/science. aba3827.

Downloads

Published

2023-05-26

How to Cite

Hutham Abd Ali Abd Al Hussain, Shymaa Hamzah Daylee, & Radhiah Najm Abd. (2023). A Review: Genetic Mutations in Hemoglobin: Sickle Cell Anemia. International Journal of Scientific Trends, 2(5), 71–75. Retrieved from https://scientifictrends.org/index.php/ijst/article/view/100

Issue

Section

Articles